Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mucoderm vs CTG for Gingival Recession with NCCL
NCT03594513Unknown
- Sponsor
- Universidade Estadual Paulista
- Start
- Jul 2018
- Primary completion
- Nov 2019
- Countries
- 1
01
Overview
Randomised, open-label trial (2 arms), sponsored by Universidade Estadual Paulista. Primary endpoint: Percentage of defect coverage at 6 months. Status: unknown.
Beyond the preview
Go deeper on NCT03594513.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03594513.